MF Tracker: Parag Parikh Flexi Cap Fund turns Rs 10,000 SIP to over Rs 51 lakh in 13 years. Too late to invest?Parag Parikh Flexi Cap Fund marks 13 years with impressive growth. A Rs 10,000 SIP since inception turned into Rs 51 lakh. The fund priorit...
Mutual funds cut technology sector exposure to 8-year low in April. Is AI disruption reshaping sentiment?Mutual funds have significantly reduced their technology sector exposure to an eight-year low, driven by concerns over AI disruption, slowi...
Jhunjhunwala-backed Bagmane Prime Office REIT lists at 3.5% premium over IPO priceBagmane Prime Office REIT debuted on the NSE at Rs 103.50, a 3.5% premium to its IPO price, following a highly subscribed Rs 3,405 crore of...
Retiring with a large EPF corpus? Here’s how to allocate money across fixed income and mutual fundsRetirees with large EPF corpus need to balance safety with growth. Financial planners advise focusing on stable, tax-efficient income gener...
These 5 flexicap funds lag peers with single-digit returns in 3 years. Check detailsFlexicap funds show wide performance divergence over three years, with laggards delivering single-digit returns while top performers genera...
Bagmane Prime Office REIT IPO: Subscribed 1.07 times on Day 2; check GMP and key detailsBagmane Prime Office REIT IPO is 83% subscribed on Day 2, driven by steady institutional and investor interest. The issue aims to raise Rs ...
Jhunjhunwala-backed Bagmane REIT IPO subscribed 71% on Day 1. Check GMP, price band and other detailsBagmane Prime Office REIT's Rs 3,405 crore IPO opened on Tuesday, aiming to list at Rs 100. Despite strong institutional backing, including...
Bandhan Small Cap & ICICI Pru Midcap among 7 equity mutual funds that have delivered over 25% CAGR over 3 yearsAbout seven equity mutual funds delivered over 25% CAGR in the past three years, out of 246 schemes analysed by ETMutualFunds. Bandhan Smal...
Jhunjhunwala trust backs Bagmane Prime Office REIT ahead of Rs 3,405 crore IPOBagmane Prime Office REIT is set to launch its IPO today, May 5. The company has secured significant backing from anchor investors, includi...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
Holding 15 mutual funds? Here’s how to cut overlap and reach Rs 2 crore goalInvestors often over-diversify with too many mutual funds, leading to duplication and management issues. A viewer's portfolio of 15 funds w...
Buy, Sell or Hold: Motilal Oswal maintains buy on UTI AMC; Goldman Sachs downgrades Dr Reddy’s LaboratoriesBrokerages remain selective, with Motilal Oswal maintaining a bullish stance on UTI AMC and Aditya Birla Sun Life AMC, citing steady AUM gr...
8 equity mutual funds multiply lumpsum investments by over 2.72x in 5 years. Are they a part of your portfolio?Around eight equity mutual funds more than doubled lump-sum investments, multiplying them over 2.72 times in the last five years, an ETMutu...
BSE loses ‘cheap’ tag post 80% rally in one year. Can Q4 performance, NSE IPO drive rerating?Shares of BSE have surged nearly 80% in a year, backed by strong derivatives growth and operating leverage. Experts see Q4 earnings and the...
UTI Mutual Fund launches new Focused Equity scheme for concentrated betsThe fund aims to put money on 30 stocks across market capitalization with the objective of generating long-term capital appreciation.
- T Rowe deal to help UTI sharpen overseas focus
UTI, with its India Fund set up in 1986, which, according to industry tracker Morningstar, is rated as one of the best performing India fun...
- UTI spreads its wings across overseas markets
Who runs the world’s oldest offshore fund set up for foreign investors? It’s UTI, with its India Fund set up in 1986, which, according to i...